---
schema_version: "secwatch.filing_event.v1"
accession: "0000719135-22-000088"
form_type: "8-K"
ticker: "APYX"
cik: "0000719135"
company_name: "Apyx Medical Corp"
filed_at: "2022-11-10T23:59:59+00:00"
generated_at: "2026-06-22T00:15:13.054646+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Apyx Medical Q3 revenue down 23% YoY; cuts full-year 2022 guidance

## Summary
- Total revenue $9.1M (-23% YoY); Advanced Energy revenue $7.1M (-31% YoY).
- Net loss $5.8M ($0.17/share) vs $4.2M loss in Q3 2021; Adjusted EBITDA loss $3.9M.
- Full-year 2022 revenue guidance cut to $44.8M-$47.9M from prior $51.0M-$56.4M.
- Company cites continued disruption from March FDA Safety Communication as primary headwind.
- OEM revenue grew 34% to $2.0M, partially offsetting Advanced Energy decline.

## SEC filing metadata
- accession: 0000719135-22-000088
- form_type: 8-K
- ticker: APYX
- cik: 0000719135
- company_name: Apyx Medical Corp
- filed_at: 2022-11-10T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/719135/000071913522000088/0000719135-22-000088-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/719135/000071913522000088/apyx-20221110.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000719135-22-000088
- JSON: https://secwatch.observer/filing/0000719135-22-000088.json
- Plain text: https://secwatch.observer/filing/0000719135-22-000088.txt

## Key facts
- Earnings Releases
  Apyx Medical Corp reported third quarter ended September 30, 2022 results: revenue $9.1 million, net income Net loss attributable to stockholders of $5.8 million. Guidance reaffirmed.
  - Period: third quarter ended September 30, 2022
  - Revenue: $9.1 million
  - Net income: Net loss attributable to stockholders of $5.8 million
  - Guidance: reaffirmed
  - Result: reported results
  source text: third quarter ended September 30, 2022, and updated financial expectations for the full year ending December 31, 2022. Third Quarter 2022 Financial Summary : • Total revenue of $9.1 million, down 23% year-over-year. ◦ Advanced Energy revenue of $7.1 million, down 31% year-over-year. ◦ OEM revenue of $2.0 million, up 34% year-over-year. • Net loss attributable to
  evidence_url: https://www.sec.gov/Archives/edgar/data/719135/000071913522000088/0000719135-22-000088-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.